Perinatal Anoxic-ischemic Brain Injury

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Perinatal Anoxic-ischemic Brain Injury trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07413900

Biomarkers Study in Infants With Prior Neonatal Brain Injury

This research focuses on the long-term cognitive development of children, including healthy infants and those who had a perinatal brain injury. As part of this…

United States100 participantsStarted 2023-03-13

All recent trials (8 shown)

By InvitationNot Applicable

NCT07264166

Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)

This international study, organized by Healing Hope International, is an observational registry designed to collect real-world data on participants living with…

Mexico25 participantsStarted 2026-03-01

Not Yet RecruitingPhase 1/2

NCT07018739

Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy

Hypoxic-ischemic encephalopathy (HIE) is a serious condition in newborns caused by lack of oxygen and blood flow around the time of birth. Standard treatment wi…

Thailand40 participantsStarted 2026-06

Treatment: Wharton's jelly-derived mesenchymal stem cells, 0.9 % Normal Saline

Perinatal Anoxic-ischemic Brain Injury

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Biomarkers Study in Infants With Prior Neonatal Brain Injury

All recent trials (8 shown)

Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)

Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Biomarkers Study in Infants With Prior Neonatal Brain Injury

All recent trials (8 shown)

Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)

Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy

Dexmedetomidine Versus Morphine During Cooling Therapy in Neonates

The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy

NVD in Hypothermic HIE Neonates

Hypothermia Enhanced by Magnesium Sulphate

CoolCap Trial, Treatment of Perinatal Hypoxic-Ischemic Encephalopathy